S'abonner

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study - 03/09/11

Doi : 10.1067/mhj.2001.114198 
Steven E. Reis, MD, a, Richard Holubkov, PhD, a, A.J.Conrad Smith, MD, a, Sheryl F. Kelsey, PhD, a, Barry L. Sharaf, MD, b, Nathaniel Reichek, MD, c, William J. Rogers, MD, d, C.Noel Bairey Merz, MDe, George Sopko, MDf, Carl J. Pepine, MDg

for the WISE Investigators

Pittsburgh, Pa, Providence, RI, Birmingham, Ala, Los Angeles, Calif, Bethesda, Md, and Gainesville, Fla 
From the aCardiovascular Institute and Department of Epidemiology, University of Pittsburgh; the bDivision of Cardiology, Department of Medicine, Rhode Island Hospital; the cDivision of Cardiology, Department of Medicine, Allegheny General Hospital; the dDivision of Cardiology, Department of Medicine, University of Alabama at Birmingham; the eDivision of Cardiology, Department of Medicine, Cedars-Sinai Medical Center; the fDivision of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute; and the gDivision of Cardiology, Department of Medicine, University of Florida 

Abstract

Background Chest pain in the absence of obstructive coronary artery disease (CAD) is common in women; it is frequently associated with debilitating symptoms and repeated evaluations and may be caused by coronary microvascular dysfunction. However, the prevalence and determinants of microvascular dysfunction in these women are uncertain. Methods We measured coronary flow velocity reserve (coronary velocity response to intracoronary adenosine) to evaluate the coronary microvasculature and risk factors for atherosclerosis in 159 women (mean age, 52.9 years) with chest pain and no obstructive CAD. All women were referred for coronary angiography to evaluate their chest pain as part of the Women’s Ischemia Syndrome Evaluation (WISE) study. Results Seventy-four (47%) women had subnormal (<2.5) coronary flow velocity reserve suggestive of microvascular dysfunction (mean, 2.02 ± 0.38); 85 (53%) had normal reserve (mean, 3.13 ± 0.64). Demographic characteristics, blood pressure, ventricular function, lipid levels, and reproductive hormone levels were not significantly different between women with normal and those with abnormal microvascular function. Postmenopausal hormone use within 3 months was significantly less prevalent among those with microvascular dysfunction (40% vs 60%, P =.032). Age and number of years past menopause correlated with flow velocity reserve (r = –0.18, P =.02, and r = –0.30, P <.001, respectively). No significant associations were identified between flow velocity reserve and lipid and hormone levels, blood pressure, and left ventricular ejection fraction. Conclusions Coronary microvascular dysfunction is present in approximately one half of women with chest pain in the absence of obstructive CAD and cannot be predicted by risk factors for atherosclerosis and hormone levels. Therefore, the diagnosis of coronary microvascular dysfunction should be considered in women with chest pain not attributable to obstructive CAD. (Am Heart J 2001;141:735-41.)

Le texte complet de cet article est disponible en PDF.

Plan


 Supported by contracts from the National Heart, Lung, and Blood Institute, contracts N01-HV-68161, N01-HV-68162, N01-HV-68163, and N01-HV-68164 and grants from the Gustavis and Louis Pfeiffer Research Foundation; the Women’s Guild, Cedars-Sinai Medical Center; Ladies Hospital Aid Society of Western Pennsylvania, University of Pittsburgh; and qmed, Inc.
☆☆ Reprint requests: Steven E. Reis, MD, c/o WISE Coordinating Center, 127 Parran Hall, 130 DeSoto St, Pittsburgh, PA 15261. E-mail: reisse@msx.upmc.edu


© 2001  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 141 - N° 5

P. 735-741 - mai 2001 Retour au numéro
Article précédent Article précédent
  • Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels
  • Joel Tsevat, Karen M. Kuntz, E.John Orav, Milton C. Weinstein, Frank M. Sacks, Lee Goldman
| Article suivant Article suivant
  • Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage
  • Robert P. Giugliano, Carolyn H. McCabe, Elliott M. Antman, Christopher P. Cannon, Frans Van de Werf, Robert G. Wilcox, Eugene Braunwald, for the Thrombolysis in Myocardial Infarction (TIMI) Investigators

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.